Oskar Bosson
Fortuna: 246 326 $ al 31/05/2026
Fortuna: 246 326 $ al 31/05/2026
Mr. Oskar Bosson is a VP, Head-Investor Relations & Communications at BioArctic AB. Mr. Bosson was previously employed as an EVP-Corporate Communications & Public Affairs by Elekta AB, a Media Officer-Specialty Chemicals by Akzo Nobel NV, and a Head-Communications by Swedish Orphan Biovitrum AB. He received his undergraduate degree from the University of Uppsala and a graduate degree from the University of Uppsala.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
BIOARCTIC AB CLASS B 0,01 % | 28/08/2025 | 6.454 ( 0,01 % ) | 246 326 $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| BIOARCTIC AB | Contacto de Relaciones con Inversores | 18/05/2020 |
| Empresas | Cargo | Fin |
|---|---|---|
| SWEDISH ORPHAN BIOVITRUM AB | Public Communications Contact | - |
| ELEKTA AB | Public Communications Contact | - |
| AKZO NOBEL N.V. | Public Communications Contact | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 5 |
|---|---|
Akzo Nobel NV
Akzo Nobel NV Industrial SpecialtiesProcess Industries Manufactures and sells decorative paints, performance coatings, and specialty chemicals | Process Industries |
Elekta AB
Elekta AB Medical SpecialtiesHealth Technology Manufactures radiation oncology and neurosurgery instruments | Health Technology |
University of Uppsala
University of Uppsala Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BioArctic AB
BioArctic AB Pharmaceuticals: MajorHealth Technology Develops drugs for patients with disorders of the central nervous systems | Health Technology |
Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB Pharmaceuticals: MajorHealth Technology Manufactures and supplies pharmaceuticals and orphan drugs in the areas of hematology, immunology and specialty care | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.